US-approved vaccines effective against B1617 variant of Covid-19: US health official

WHO classified the B1617 SARS-CoV-2 variant, and confirmed that the variant was first detected in India

Comments

Popular posts from this blog

MUDA scam: Karnataka Lokayukta seeks more time to submit final report

Maha-Karnataka language row: Family to withdraw POCSO case against conductor

RTC bus staff attack: Kannada organisations call for Karnataka bandh on March 22